Mindray Launches Project 2030, Eyes Future of Women’s Ultrasound
On September 15th, at ISUOG 2025 World Congress in Cancun, Mexico, Mindray unveiled Project 2030, an initiative to improve global access to ultrasound technology. The project was...
Category : Healthcare and Pharmaceutical
GCCL, Frontage Labs Partner to Boost Global Trial Capabilities
GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, and Frontage Laboratories, Inc., a USA based full-service contract research organization (CRO), announced...
Novartis Data Backs Kesimpta® Benefits After Therapy Switch
Novartis today announced new data from two Kesimpta® (ofatumumab) studies in relapsing multiple sclerosis (RMS) that will be presented at the European Committee for Treatment and...
Leqembi® Approved in Australia for Early Alzheimer’s Treatment
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) for the treatment of adult patients with mild...
Xeltis Advances Toward Commercialization After aXess Trial Data
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces successful clinical data from the aXess...
SynGenSys Launches NK.SET Library for NK Cell Therapy Advances
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced...
Elara Caring, National HME Partner on Medical Equipment Services
Elara Caring, a leading national home health provider offering high-quality clinical and personal care services, and National HME, a leading provider of durable medical equipment...
VedaBio, Siemens Healthineers Raise $25M for Molecular Tech
VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a Series A extension alongside a strategic agreement with Siemens Healthineers. Together, these commitments total...
Douglas Emslie Joins Life Science Connect Board for Live Events
Life Science Connect (“LSC”) is pleased to announce the appointment of Douglas Emslie to its Board of Directors. Mr. Emslie will focus his efforts on...
Drug Farm Partners with Cincinnati Children’s on ALPK1 Inhibitor
Dr. Daniel Starczynowski joins Drug Farm Scientific Advisory Board Drug Farm, a private biotechnology company utilizing genetics and artificial intelligence technologies to discover and develop...
Kayothera Nominates KAYO-1732 for Diabetes, Cardiometabolic Use
Kayothera, Inc. (“Kayothera”), a preclinical therapeutics company developing first-in-class, small molecule inhibitors of the retinoid nuclear receptor pathway, today announces that it has selected KAYO-1732...
Thynk Health Names Matt Rockhold to Boost AI Cancer Detection
Thynk Health, a leading innovator in AI-powered diagnostic platforms, today announced the appointment of Matt Rockhold as Chief Commercial Officer. In this role, Rockhold will lead the...
Trinity Capital Invests $45M in Rapid Micro Biosystems
Trinity Capital Inc. (Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced the commitment of $45 million in growth capital to Rapid Micro Biosystems (Nasdaq: RPID) (“Rapid Micro”),...
Flight Health Buys Alteris for AI Operating System in Med
Flight Health, the digital health company building the AI operating system for independent medical practices, today announced the acquisition of Alteris Health, a healthcare automation...
BD & Henry Ford Health Partner on Pharmacy Automation
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a pharmacy automation partnership with Henry Ford Health to develop the health system...